This content is restricted.
Brief
The French National Agency for Medicines and Health Products Safety (ANSM) conducted an inspection at Sofibel's Levallois-Perret facility from June 12 to 14, 2024. The inspection revealed significant non-conformities and shortcomings, which were notified to the establishment in a letter on August 20, 2024. The ANSM found insufficient controls over critical suppliers and subcontractors, inadequate technical documentation for the Sterimar product, and insufficient biocharge management. As a result, Sofibel was ordered to establish satisfactory measures within specified timeframes.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested